Article
Advancing translational research for colorectal immuno-oncology
10 Aug 2023
Abstract excerpt
Colorectal cancer (CRC) is a common and deadly disease. Unfortunately, immune checkpoint inhibitors (ICIs) fail to elicit effective anti-tumour responses in the vast majority of CRC patients. Patients that are most likely to respond are those with DNA mismatch repair deficient (dMMR) and microsatellite instability (MSI) disease. However, reliable predictors of ICI response are lacking, even within the dMMR/MSI...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
